Castro Rui, Sequeira Maria José, Sameiro Faria Maria, Belmira Ana, Sampaio Susana, Roquete Pedro, Silvestre Federico, Rocha Cândido, Morgado Teresa
Serviço de Anatomia Patológica, Hospital Geral S. António, Porto.
Acta Med Port. 2004 Jan-Feb;17(1):20-6. Epub 2004 Feb 27.
Renal biopsy is a fundamental tool in the diagnosis and prognostic of multiple nephrological and systemic pathologies. At our institution the first patient submitted to this technique, at 1994, showed Berger disease. Until 2002 we have performed 91 renal biopsies (57 men and 34 women) with the following annual distribution: 1994 (n=3), 1995 (n=3), 1996 (n=3), 1997 (n=15), 1998 (n=5), 1999 (n=23), 2000 (n=13) and 2001 (n=26). Ultrasound guidance was always used and in most of cases the technique was performed with Vim-Silverman (14G) needle. BARD automatic system was employed in only five patients. The clinical diagnosis that lead to renal biopsy were: nephrotic syndrome (n=27), asyntomatic urinary abnormalities (n=25), acute or rapidly progressive renal failure (n=18), chronic renal failure (n=15), hypertension (n=4) and acute nephritis (n=2). The efficacy for optic histological diagnosis was 92.3% (84/91). However, if we include seven cases of presumed IgA nephropathy that don't included fragment for immunofluorescence (IF) analysis the efficacy declined to 84.6% (77/91). The mean number of glomeruli per fragment was 18.3 -/+ 14.2 [0-80]. Histological diagnosis were the following: Berger disease (n=24), idiopathic nephrotic syndrome (n=18), lupus nephritis (n=8), mesangial proliferative glomerulonephritis without glomeruli in the IF fragment (n=6), without glomeruli (n=6), secondary nephrotic syndrome (n=4), tubulointerstitial nephritis or acute tubular necrosis (n=4), diabetic nephropathy (n=3), myeloma kidney (n=3), pauci-imune and crescentic glomerulonephritis (n=3), hypertensive nephropathy (n=2), IgM mesangial proliferative glomerulonephritis (n=2) and various (n=8). Gross hematuria appeared in 9 patients (9.9%). Only in three of these patients it was showed, by ecography, the existence of kidney haematoma. Bleeding throughout the mandrill in four cases, leaded to transfusion in only three patients. We have registered one accidental spleen puncture. Nephrectomy for incontrollable bleeding was never needed. Higher glomerulosclerosis (30% vs 8%; p<0.01) and also a greater extent of tubulointersticial lesions (100% vs 63%; p<0.01), were predictors of progression into end-stage or advanced renal failure. Concluding, renal biopsy with ultrasound guidance was valuable for diagnosis in 84.6% of our proceedings. Our serie is similar to others concerning serious complications. Nephrologists and radiologists improved progressively their coordination performing this technique, improving the results during this period of 8 years.
肾活检是诊断多种肾脏及全身性疾病并判断预后的一项基本手段。1994年,我院首例接受该技术的患者被诊断为伯杰氏病。截至2002年,我们共进行了91例肾活检(57例男性,34例女性),其年度分布如下:1994年(n = 3),1995年(n = 3),1996年(n = 3),1997年(n = 15),1998年(n = 5),1999年(n = 23),2000年(n = 13)以及2001年(n = 26)。所有操作均采用超声引导,多数情况下使用Vim-Silverman(14G)穿刺针,仅5例患者使用了BARD自动活检系统。导致进行肾活检的临床诊断包括:肾病综合征(n = 27)、无症状性尿液异常(n = 25)、急性或急进性肾衰竭(n = 18)、慢性肾衰竭(n = 15)、高血压(n = 4)以及急性肾炎(n = 2)。光学组织学诊断的成功率为92.3%(84/91)。然而,如果将7例未进行免疫荧光(IF)分析的疑似IgA肾病病例纳入计算,成功率则降至84.6%(77/91)。每个活检组织块的肾小球平均数量为18.3 ± 14.2 [0 - 80]。组织学诊断结果如下:伯杰氏病(n = 24)、特发性肾病综合征(n = 18)、狼疮性肾炎(n = 8)、IF活检组织块中无肾小球的系膜增生性肾小球肾炎(n = 6)、无肾小球(n = 6)、继发性肾病综合征(n = 4)、肾小管间质性肾炎或急性肾小管坏死(n = 4)、糖尿病肾病(n = 3)、骨髓瘤肾病(n = 3)、寡免疫性新月体性肾小球肾炎(n = 3)、高血压肾病(n = 2)、IgM系膜增生性肾小球肾炎(n = 2)以及其他(n = 8)。9例患者(9.9%)出现肉眼血尿。其中仅3例经超声检查发现存在肾血肿。4例患者活检过程中出现出血,仅3例需要输血。我们记录到1例意外脾脏穿刺。从未因出血无法控制而进行肾切除术。肾小球硬化程度较高(30% 对 8%;p < 0.01)以及肾小管间质病变范围更大(100% 对 63%;p < 0.01)是进展至终末期或晚期肾衰竭的预测因素。总之,超声引导下肾活检在我们84.6%的病例中对诊断具有重要价值。我们的病例系列在严重并发症方面与其他类似。在此8年期间,肾内科医生和放射科医生在进行这项技术时逐渐改善了协作,从而提高了结果。